239 related articles for article (PubMed ID: 23208604)
1. Multilaboratory approach to preclinical evaluation of vaccine immunogens for placental malaria.
Fried M; Avril M; Chaturvedi R; Fernandez P; Lograsso J; Narum D; Nielsen MA; Oleinikov AV; Resende M; Salanti A; Saveria T; Williamson K; Dicko A; Scherf A; Smith JD; Theander TG; Duffy PE
Infect Immun; 2013 Feb; 81(2):487-95. PubMed ID: 23208604
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to Escherichia coli-expressed C-terminal domains of Plasmodium falciparum variant surface antigen 2-chondroitin sulfate A (VAR2CSA) inhibit binding of CSA-adherent parasites to placental tissue.
Saveria T; Oleinikov AV; Wiliamson K; Chaturvedi R; Lograsso J; Keitany GJ; Fried M; Duffy P
Infect Immun; 2013 Apr; 81(4):1031-9. PubMed ID: 23319559
[TBL] [Abstract][Full Text] [Related]
3. Designing a VAR2CSA-based vaccine to prevent placental malaria.
Fried M; Duffy PE
Vaccine; 2015 Dec; 33(52):7483-8. PubMed ID: 26469717
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
Pinto VV; Ditlev SB; Jensen KE; Resende M; Dahlbäck M; Andersen G; Andersen P; Theander TG; Salanti A; Nielsen MA
PLoS One; 2011 Mar; 6(3):e17942. PubMed ID: 21464946
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates.
Avril M; Hathaway MJ; Srivastava A; Dechavanne S; Hommel M; Beeson JG; Smith JD; Gamain B
PLoS One; 2011 Feb; 6(2):e16622. PubMed ID: 21326877
[TBL] [Abstract][Full Text] [Related]
6. Strain-transcendent immune response to recombinant Var2CSA DBL5-ε domain block P. falciparum adhesion to placenta-derived BeWo cells under flow conditions.
Fernandez P; Petres S; Mécheri S; Gysin J; Scherf A
PLoS One; 2010 Sep; 5(9):e12558. PubMed ID: 20838433
[TBL] [Abstract][Full Text] [Related]
7. Structure of the DBL3X-DBL4ε region of the VAR2CSA placental malaria vaccine candidate: insight into DBL domain interactions.
Gangnard S; Lewit-Bentley A; Dechavanne S; Srivastava A; Amirat F; Bentley GA; Gamain B
Sci Rep; 2015 Oct; 5():14868. PubMed ID: 26450557
[TBL] [Abstract][Full Text] [Related]
8. High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.
Tutterrow YL; Avril M; Singh K; Long CA; Leke RJ; Sama G; Salanti A; Smith JD; Leke RG; Taylor DW
Infect Immun; 2012 Apr; 80(4):1479-90. PubMed ID: 22331427
[TBL] [Abstract][Full Text] [Related]
9. VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.
Gangnard S; Chêne A; Dechavanne S; Srivastava A; Avril M; Smith JD; Gamain B
Sci Rep; 2019 Nov; 9(1):16978. PubMed ID: 31740695
[TBL] [Abstract][Full Text] [Related]
10. Var2CSA DBL6-epsilon domain expressed in HEK293 induces limited cross-reactive and blocking antibodies to CSA binding parasites.
Fernandez P; Viebig NK; Dechavanne S; Lépolard C; Gysin J; Scherf A; Gamain B
Malar J; 2008 Sep; 7():170. PubMed ID: 18771584
[TBL] [Abstract][Full Text] [Related]
11. VAR2CSA Domain-Specific Analysis of Naturally Acquired Functional Antibodies to Plasmodium falciparum Placental Malaria.
Doritchamou JY; Herrera R; Aebig JA; Morrison R; Nguyen V; Reiter K; Shimp RL; MacDonald NJ; Narum DL; Fried M; Duffy PE
J Infect Dis; 2016 Aug; 214(4):577-86. PubMed ID: 27190180
[TBL] [Abstract][Full Text] [Related]
12. Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins.
Avril M; Cartwright MM; Hathaway MJ; Smith JD
Malar J; 2011 Feb; 10():36. PubMed ID: 21314945
[TBL] [Abstract][Full Text] [Related]
13. Murine Model for Preclinical Studies of Var2CSA-Mediated Pathology Associated with Malaria in Pregnancy.
de Moraes LV; Dechavanne S; Sousa PM; Barateiro A; Cunha SF; Nunes-Silva S; Lima FA; Murillo O; Marinho CRF; Gangnard S; Srivastava A; Braks JA; Janse CJ; Gamain B; Franke-Fayard B; Penha-Gonçalves C
Infect Immun; 2016 Jun; 84(6):1761-1774. PubMed ID: 27045035
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant duffy binding-like-gamma3 induces pan-reactive and adhesion-blocking antibodies against placental chondroitin sulfate A-binding Plasmodium falciparum parasites.
Costa FT; Fusaï T; Parzy D; Sterkers Y; Torrentino M; Douki JB; Traoré B; Petres S; Scherf A; Gysin J
J Infect Dis; 2003 Jul; 188(1):153-64. PubMed ID: 12825185
[TBL] [Abstract][Full Text] [Related]
15. Structural and functional insight into how the Plasmodium falciparum VAR2CSA protein mediates binding to chondroitin sulfate A in placental malaria.
Clausen TM; Christoffersen S; Dahlbäck M; Langkilde AE; Jensen KE; Resende M; Agerbæk MØ; Andersen D; Berisha B; Ditlev SB; Pinto VV; Nielsen MA; Theander TG; Larsen S; Salanti A
J Biol Chem; 2012 Jul; 287(28):23332-45. PubMed ID: 22570492
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria.
Bir N; Yazdani SS; Avril M; Layez C; Gysin J; Chitnis CE
Infect Immun; 2006 Oct; 74(10):5955-63. PubMed ID: 16988275
[TBL] [Abstract][Full Text] [Related]
17. The chondroitin sulfate A-binding site of the VAR2CSA protein involves multiple N-terminal domains.
Dahlbäck M; Jørgensen LM; Nielsen MA; Clausen TM; Ditlev SB; Resende M; Pinto VV; Arnot DE; Theander TG; Salanti A
J Biol Chem; 2011 May; 286(18):15908-17. PubMed ID: 21398524
[TBL] [Abstract][Full Text] [Related]
18. A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates.
Doritchamou JYA; Renn JP; Jenkins B; Mahamar A; Dicko A; Fried M; Duffy PE
Elife; 2022 Feb; 11():. PubMed ID: 35103596
[TBL] [Abstract][Full Text] [Related]
19. The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site.
Babakhanyan A; Leke RG; Salanti A; Bobbili N; Gwanmesia P; Leke RJ; Quakyi IA; Chen JJ; Taylor DW
PLoS One; 2014; 9(2):e88173. PubMed ID: 24505415
[TBL] [Abstract][Full Text] [Related]
20. Evidence for globally shared, cross-reacting polymorphic epitopes in the pregnancy-associated malaria vaccine candidate VAR2CSA.
Avril M; Kulasekara BR; Gose SO; Rowe C; Dahlbäck M; Duffy PE; Fried M; Salanti A; Misher L; Narum DL; Smith JD
Infect Immun; 2008 Apr; 76(4):1791-800. PubMed ID: 18250177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
